RECITALSLicense Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Virginia
Contract Type FiledApril 30th, 2003 Company Industry Jurisdiction
AGREEMENTConfidentiality Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
Contract Type FiledApril 30th, 2003 Company Industry
EXHIBIT 10.42 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. LICENSE AGREEMENT This LICENSE...License Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
Contract Type FiledApril 30th, 2003 Company Industry
AcSentient, Inc. 110 Doric Court Morrisville, NC 27560 April 26, 2002 Eastern Virginia Medical School 825 Fairfax Avenue Norfolk, VA 23507 Re: Sale of Certain Assets of AcSentient, Inc. to ISTA Pharmaceuticals, Inc. Dear Dr. Bell: Pursuant to an Asset...Asset Purchase Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
Contract Type FiledApril 30th, 2003 Company IndustryPursuant to an Asset Purchase Agreement, AcSentient, Inc. ("AcSENTIENT") is selling to ISTA Pharmaceuticals, Inc. ("ISTA") certain assets including the License Agreement by and between Eastern Virginia Medical School, dated January 29, 2002 (the "LICENSE").
ADDENDUMLicense Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Virginia
Contract Type FiledApril 30th, 2003 Company Industry Jurisdiction
EXHIBIT 10.45 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDMENT TO BROMFENAC LICENSE...Bromfenac License Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
Contract Type FiledApril 30th, 2003 Company Industry
EXHIBIT 10.46 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDMENT TO TIMOLOL AGREEMENT This...Timolol Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
Contract Type FiledApril 30th, 2003 Company Industry